药物对比
Linagliptin vs Bexagliflozin
比较 Linagliptin 与 Bexagliflozin 治疗2型糖尿病。DPP-4与SGLT2：作用机制、心脏/肾脏获益、体重、低血糖风险和副作用。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes comparing DPP-4 inhibitors like linagliptin to SGLT2 inhibitors like bexagliflozin when considering oral add-on therapy or switching based on comorbidities.
结论
Neither drug is universally better; bexagliflozin provides extra cardiorenal benefits while linagliptin is a reliable, well-tolerated DPP-4 option.
全部药物对比